Free Trial
LON:CRTX

CRISM Therapeutics (CRTX) Share Price, News & Analysis

GBX 10
0.00 (0.00%)
(As of 11/4/2024 ET)

About CRISM Therapeutics Stock (LON:CRTX)

Key Stats

Today's Range
9.12
10
50-Day Range
N/A
52-Week Range
5
30.90
Volume
3,461 shs
Average Volume
109,658 shs
Market Capitalization
£3.27 million
P/E Ratio
1.22
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

CRISM Therapeutics Corporation focuses on drug delivery technology to improve the clinical performance of cancer drugs as treatments for solid tumors. Its lead product, ChemoSeed that can be implanted directly into a tumor or the resection margin following the removal of a tumor, ensuring effective therapeutic concentrations of chemotherapy drugs directly reach the tumor tissue. Its ChemoSeed used for treatment of gliomas, a brain tumor. The company was founded in 2016 and is based in Road Town, the British Virgin Islands.

Receive CRTX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for CRISM Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

CRTX Stock News Headlines

No headlines for this company have been tracked by MarketBeat.com

CRTX Stock Analysis - Frequently Asked Questions

CRISM Therapeutics' stock was trading at GBX 11.90 at the beginning of the year. Since then, CRTX stock has decreased by 16.0% and is now trading at GBX 10.
View the best growth stocks for 2024 here
.

Shares of CRTX stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

Industry, Sector and Symbol

Industry
Other Industrial Metals & Mining
Sub-Industry
N/A
CIK
N/A
Phone
N/A
Fax
N/A
Employees
4
Year Founded
N/A

Profitability

Net Income
£-1,770,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Book Value
GBX 6 per share

Miscellaneous

Free Float
N/A
Market Cap
£3.27 million
Optionable
N/A
Beta
0.81
The Best High-Yield Dividend Stocks for 2024 Cover

Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.

Get This Free Report

This page (LON:CRTX) was last updated on 11/4/2024 by MarketBeat.com Staff
From Our Partners